Stockholm - Delayed Quote SEK

BioGaia AB (publ) (BIOG-B.ST)

Compare
111.20
-4.30
(-3.72%)
At close: 5:29:57 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,355,662.00
1,296,505.00
1,103,958.00
785,111.00
747,077.00
Cost of Revenue
358,065.00
346,316.00
302,028.00
202,161.00
200,159.00
Gross Profit
997,598.00
950,190.00
801,929.00
582,949.00
546,918.00
Operating Expense
598,932.00
508,933.00
467,262.00
340,352.00
301,341.00
Operating Income
398,666.00
441,257.00
334,667.00
242,597.00
245,577.00
Net Non Operating Interest Income Expense
46,003.00
40,723.00
2,577.00
-1,025.00
-567.00
Pretax Income
431,523.00
468,834.00
447,613.00
252,712.00
227,583.00
Tax Provision
94,705.00
103,482.00
73,840.00
56,439.00
47,853.00
Net Income Common Stockholders
336,818.00
365,352.00
373,773.00
196,273.00
179,730.00
Diluted NI Available to Com Stockholders
336,818.00
365,352.00
373,773.00
196,273.00
179,730.00
Basic EPS
3.34
3.62
3.70
1.94
2.01
Diluted EPS
3.34
3.62
3.70
1.94
2.01
Basic Average Shares
101,049.50
100,982.00
100,982.00
100,982.00
89,240.32
Diluted Average Shares
101,056.25
100,982.00
100,982.00
100,982.00
89,275.00
Total Operating Income as Reported
400,512.00
443,103.00
361,459.00
253,737.00
228,150.00
Total Expenses
956,997.00
855,249.00
769,290.00
542,513.00
501,500.00
Net Income from Continuing & Discontinued Operation
336,818.00
365,352.00
373,773.00
196,273.00
179,730.00
Normalized Income
348,519.75
377,045.76
303,568.32
196,273.00
179,730.00
Interest Income
49,534.00
41,532.00
7,963.00
107.00
155.00
Interest Expense
3,531.00
809.00
5,386.00
1,132.00
722.00
Net Interest Income
46,003.00
40,723.00
2,577.00
-1,025.00
-567.00
EBIT
435,054.00
469,643.00
452,999.00
253,844.00
228,305.00
EBITDA
511,556.00
494,924.00
476,889.00
281,085.00
248,835.00
Reconciled Cost of Revenue
358,065.00
346,316.00
302,028.00
202,161.00
200,159.00
Reconciled Depreciation
76,502.00
25,281.00
23,890.00
27,241.00
20,530.00
Net Income from Continuing Operation Net Minority Interest
336,818.00
365,352.00
373,773.00
196,273.00
179,730.00
Total Unusual Items Excluding Goodwill
-14,992.00
-14,992.00
83,577.00
--
--
Total Unusual Items
-14,992.00
-14,992.00
83,577.00
--
--
Normalized EBITDA
526,548.00
509,916.00
393,312.00
281,085.00
248,835.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-3,290.25
-3,298.24
13,372.32
--
--
12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

068760.KQ Celltrion Pharm, Inc.
56,300.00
-1.05%
 
29A.SG Amphastar Pharmaceuticals Inc
34.54
-1.65%
 
0ET.MU Esperion Therapeutics Inc
2.1980
+2.66%
 
VISTN.OL Vistin Pharma ASA
23.10
-1.28%
 
PROB.ST Probi AB (publ)
349.00
-0.29%
 
R9U2.F Green Thumb Industries Inc.
7.20
-2.90%
 
SHMN SOHM, Inc.
0.0007
0.00%
 
HLUN-B.CO H. Lundbeck A/S
39.60
-2.46%
 
CEL.L Celadon Pharmaceuticals Plc
16.00
0.00%
 
SOBI.ST Swedish Orphan Biovitrum AB (publ)
320.80
+2.43%